Bruker Spatial Biology, a division of Bruker Corporation, provides advanced spatial molecular biology solutions, including instruments, assays, software, and services to support life sciences research. By integrating technologies from NanoString and Canopy Biosciences, Bruker offers an extensive portfolio designed to meet the diverse needs of global researchers exploring spatial biology. The CosMx® Spatial Molecular Imager (SMI) enables high-plex detection and analysis of over 6,000 RNAs with single-cell resolution and precise cell segmentation, supported by the cloud-based AtoMx™ Spatial Informatics Platform. The GeoMx® Digital Spatial Profiler is a leading platform for whole-tissue exploration, providing whole transcriptomics and high-plex proteomic readouts. The CellScape™ Precise Spatial Proteomics platform allows for high-plex protein expression analysis at single-cell resolution, using versatile, open-sourced reagents. The nCounter® Analysis System enables rapid quantification of profiling of gene and miRNA expression with high sensitivity. Together, Bruker Spatial Biology’s solutions are supported by a strong team of scientists, sales, and service associates, along with Canopy Multiomic Services for biopharmaceutical research, assay development, and clinical sample testing. For more information, visit www.BrukerSpatialBiology.com.

10x Genomics builds solutions to interrogate biological systems at a resolution and scale that matches the complexity of biology. Our end-to-end single cell and spatial solutions include instruments, consumables, and intuitive software, letting you unravel highly intricate biological systems, while bringing into focus the details that matter most.

Cell Signaling Technology (CST) is dedicated to meeting the unique needs of Researchers by providing tailored solutions for drug discovery and development projects. Our commitment to delivering high-quality tools, reagents, and services aligns with the precision and efficiency required in the pharmaceutical and biotech industries. Oxford Global members can rely on CST’s comprehensive portfolio of verified products designed to support research areas such as oncology, immunotherapy, neurodegeneration, and targeted protein degradation. Whether you require off-the-shelf reagents, customized formulations for consistency, or specialized services matched to your research goals, CST is your trusted partner in accelerating drug discovery processes and achieving successful outcomes.

Element Biosciences is a multi-disciplinary startup founded in 2017 and focused on innovating genetic analysis tools for the research markets. Our mission is to empower the scientific community with more freedom and flexibility to accelerate our collective impact on humanity. Visit our booth and meet the Element AVITI™ System, a benchtop DNA sequencing platform with unprecedented performance, cost, and flexibility. Our proprietary approach to improving the signal-to-noise ratio allows us to provide groundbreaking innovations in surface chemistry, instrumentation, and biochemistry to drastically decrease the run cost and capital cost while delivering high sequencing data quality. Check out our website today to learn more about AVITI with spec sheets, app notes, sequencing datasets and more.

Lunaphore Technologies S.A. – a Bio-Techne brand, is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore provides solutions based on a game-changing chip technology that can extract spatial proteomic and transcriptomic data from tumors and other tissues, transforming any assay into multiplex spatial biology through a streamlined and easily integrated process. Lunaphore empowers researchers in immunology, immuno-oncology, and neuroscience to push the boundaries of scientific discovery and drug development. Lunaphore’s technology enables the identification of biomarker “signatures” with clinical relevance to support the development of diagnostic tools and streamline clinical trials, to ultimately improve patient outcomes. For further information on Lunaphore and its products, please visit https://lunaphore.com.

ACD - a Bio-Techne brand, is a pioneer and leader in the advancement of spatial genomics and clinical applications by unlocking the power of RNA and developing cell- and tissue-based research and diagnostic tests for personalized medicine. Based in Silicon Valley, ACD’s proprietary RNAscope™ technology, the first multiplex fluorescent and chromogenic in situ hybridization platform, enables detection and quantification of single RNA molecules in situ. Our portfolio includes, RNAscope, BaseScope™, miRNAscope™ and HiPlex™ v2. With over 50,000 probes and our Professional Assay Services, we enable rapid assessment of unique targets. Since launch in 2011, the technology boasts 10,000+ citations, with new peer reviewed publications daily. Based on proprietary technology, ACD’s RNAscope Technology, the first multiplex fluorescent and chromogenic in situ hybridization platform enables detection and quantification of RNA in situ at single molecule sensitivity.

ariadne.ai ag is your partner for biomedical image analysis. Our cloud-based, worry-free SPATIAL platform enables the analysis of multiplexed spatial proteomics, transcriptomics and multi-omics data, including precise stitching, registration, segmentation and statistical analyses of cellular neighborhoods. SPATIAL works with any data type, whether you have fluorescence or histopathological staining, 2d or 3d data, or complex cell types such as neurons. Our experienced team of annotators and software engineers will design and implement custom solutions to any image analysis challenge, no matter the tissue, device or assay.

Canopy Biosciences®, a Bruker company, empowers innovation by providing access to cutting-edge spatial biology and multi-omic tools so biomedical researchers can drive scientific discovery faster. Our flagship CellScape™ Precise Spatial Multiplexing platform is a multiplex immunofluorescence imaging system for the whole-slide analysis of complex tissues and mapping of cell populations with single-cell resolution. Supported by Canopy Spatial Services, we provide a unique collection of spatial and single-cell technologies that accelerate the understanding of cellular diversity and interaction. Learn more at CanopyBiosciences.com.

For over 30 years, Miltenyi Biotec has been a leader in the development of products that empower the advancement of biomedical research and enable cell and gene therapy. We provide innovative tools to help with your sample preparation, cell isolation, cell culture, and cell analysis needs. Our Spatial Biology solutions include ultrahigh-plexed immunofluorescence and 3D light sheet imaging to support research applications for immunology, stem cell biology, neuroscience, and cancer.

Singular Genomics is driving innovation at the forefront of multiomics. Dedicated to supporting the scientific community, we focus on creating scientific advancements influenced by real-world feedback and solution-oriented development. As a publicly-traded life science technology company, we specialize in advanced next-generation sequencing (NGS) and multiomic technologies, developing products that empower researchers and clinicians. The G4 Sequencing Platform, our first commercially available product, is an innovative benchtop sequencer featuring a novel 4-color rapid sequencing-by-synthesis (SBS) chemistry and advanced engineering, providing single-day turnaround times for various applications. Our recently launched G4X Spatial Sequencer, which is an upgrade to the G4 Sequencing Platform, is designed to offer high throughput in situ direct sequencing of RNA (Direct-Seq™), targeted transcriptomics, and proteomics profiling from formalin-fixed, paraffin-embedded (FFPE) tissues. We are committed to unlocking the potential of our core technologies to reshape the future of multiomics. We offer a dynamic, fast-paced, results-oriented environment where employees can make a significant impact. Innovation, continuous learning, multi-disciplinary collaboration, and diversity of thought are pillars of our culture.

Standard BioTools™, previously known as Fluidigm®, is driven by a bold vision – Unleashing tools to accelerate breakthroughs in human health. Standard BioTools provides essential, standardized technologies that empower customers to scale and accelerate their research through delivery of consistent, reliable, and repeatable results.

Sponsor biography coming soon

Company Profile MMI Molecular Machines & Industries (MMI) is the leading provider of microscopic single cell isolation tools. We specialize in single cell separation, laser microdissection and optical tweezers for a wide range of clinical and research-based applications in life sciences, material sciences, and healthcare. MMI is a high value partner for our customers providing worldwide unique competence in micromanipulation and single cell handling. The modular design of our products enables us to deliver instruments that are tailored to your individual needs and your specific applications. Dedicated software packages offer simple and precise experimental control as well as full documentation. We understand that your lab equipment needs to meet the unique demands of your individual research projects. Talk to us about your requirements: our experienced team creates individual software and hardware solutions and supports you with our latest upgrade options – all life long. The MMI CellCut uses laser microdissection technology for the quick and precise isolation of cells and tissue. A large variety of sample types including fresh frozen tissues, paraffin embedded archived slides, cytospins, smears and live cells can all be used. The technology supports a plethora of downstream applications including Microarrays, qPCR and NextGen Sequencing The MMI CellEctor is a microscope based capillary single cell sorting system for rapid recognition, acquisition and deposition of single or rare cells in suspension. The CellEctor is a favorite of researchers working with Circulating Tumor Cells and Fetal Blood Cells. The MMI CellManipulator is a powerful optical multibeam tweezers system based on the mechanical forces arising from a strongly focused laser beam. It enables comfortable, ultra-precise and contact-free manipulation of microscopic particles, single or living cells, or subcellular organisms and the measurement of intracellular activities. Prof. Dr. Stefan Seeger founded the company in 1992. MMI has its headquarters in Eching near Munich, Germany and runs additional offices in Zurich, Switzerland and Haslett, USA. MMI has more than 20 years experience, representatives in over 65 countries and more than 500 system installations worldwide.

RareCyte provides Precision Biology™ products and services for discovery, translational research and clinical diagnostics. The Orion™ spatial biology platform enables whole-slide highly multiplexed tissue analysis for multiple samples per day. Comprehensive liquid biopsy offerings enable CTC and other rare cell characterization and single cell retrieval for molecular analysis and CDx development.

Sponsor biography coming soon

Hamilton’s automated liquid handling systems empower labs worldwide but are just one part of our overall lab capabilities. Our comprehensive technologies work together to create customized solutions for your workflows.

Omicsveu is a Spatial Multiplex Multiomics company with a mission to design, develop, and commercialize high-throughput, fully automated, and integrated systems. NanoVIP, an open system equipped with 30 slides* and in situ PCR capabilities, is designed to automate any slide-based assay, including Immunoveu (Phenomics), RNAveu (Transcriptomics), miRNAveu, and multi-omics — co-localization of DNA, mRNA, miRNA, and proteins. NanoVIP comes with fully optimized protocols for commercially available spatial biology assays, including but not limited to OPAL, Hyperion, and RNAscope. The thirty* onboard in situ PCR systems are most appropriate to support the automation of spatial transcriptomics systems. Additionally, the system’s smart design reduces hands-on time by 80%, reagent consumption by up to 90%, and training time for new laboratory personnel by 70%, all while maintaining high throughput. With ready-to-use reagents, visualization kits, multiplexed antibodies, and optimized protocols, Omicsveu integrates seamlessly into lab workflows, delivering reliable, reproducible, and quantifiable high-precision results that drive advancements in precision medicine through innovative multi-omics systems. *Available in both 30-slide and 10-slide configurations.